Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs.
about
Identification of cisplatin-regulated metabolic pathways in pluripotent stem cellsPotentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindolesCombination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPKOverexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors.ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae.Resistance to chemotherapy in cancer: a complex and integrated cellular response.DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancerGlutathione alleviated peripheral neuropathy in oxaliplatin-treated mice by removing aluminum from dorsal root ganglia.Analytical methodologies for metallomics studies of antitumor Pt-containing drugs.Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.Metal complex interactions with DNA.The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry.Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.Synthesis, cytotoxicity, and apoptosis induction study of antitumor dinuclear platinum(II) complexes.Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.Capsaicin induces apoptosis of cisplatin-resistant stomach cancer cells by causing degradation of cisplatin-inducible Aurora-A protein.Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies.Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.Substitution reactions of [Pt(terpy)X]2+ with some biologically relevant ligands. Synthesis and crystal structure of [Pt(terpy)(cyst-S)](ClO4)2.0.5H2O and [Pt(terpy)(guo-N7)](ClO4)2.0.5guo.1.5H2O.Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.Reactivity of kiteplatin with S-donor biomolecules and nucleotidesAn Updated View of Cisplatin Transport
P2860
Q28534469-9F0AB5FD-D9C7-4A46-B085-E3CBB3B85C83Q28546440-2C95F188-10B4-4511-AA77-3093CB3E7DD6Q33798999-5A36AC33-AADB-4A16-8429-8B83D449585DQ34159386-D74DDEF7-FFD1-4A16-9061-70432DE99151Q34424018-1D8DE65D-783A-40D3-AF8C-D05C59B17F7EQ34482184-4DF50C09-9CED-42D4-B8C4-033F4097F106Q35751980-0E25641A-598B-4B64-AB9E-902AA51BED7AQ36669884-C570E139-C8BD-41F2-A831-19D747B49E14Q36798320-9D6B8BA3-DA70-4006-9DC0-1F1D0C797CF4Q36952570-500B4D82-7147-4243-BA3F-26DEBCE44B20Q37079652-8585AD6A-C24B-46ED-99D2-61C0FD5BD0BEQ37276254-FDA59DB2-9CF1-491A-90AB-41C8D2FE7971Q37732947-23AE8E83-E77A-4EF1-BD51-1BA6633F5FE6Q37808951-41FB4086-DFF2-4C2B-844B-D9FE87D26F31Q38034439-730163A6-0746-4A7C-B48C-A0F91FE4347BQ38271731-421C7ABD-7D2F-463C-BA36-30E8A5A957E2Q38356787-F992F2A6-C4AD-478A-BDB6-273BE8B6C2A1Q39089137-99274655-5CAC-4BD0-A062-BA0D51C4CD50Q39187485-E6FEE6B6-1BF6-48A6-93DA-3E1D7235CA50Q39235908-604CF0FA-3A2E-42BB-9450-1B28560FCCEDQ39424293-97293B5F-CF8A-4711-BF38-256DDC94652AQ39471062-F50430E4-4B57-4BB9-A486-63E3CE364507Q39554731-205E76EC-4913-4545-A634-44D9198C8353Q39737951-05EDBACA-4428-4D3B-B24F-7B263B49B2E8Q45051126-F6D2EA89-4DB9-410C-9E13-CD37CBB5590BQ55261457-E6F6D0B9-DB37-4DC5-8832-5DD90BE14EA5Q59172303-A9015FA6-4DBC-4B39-8D5E-2AFA01CB7551Q59172334-0FB37FCE-E723-4614-B5C2-C1B2321D6EE9
P2860
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Glutathione induces cellular r ...... ear platinum anticancer drugs.
@en
type
label
Glutathione induces cellular r ...... ear platinum anticancer drugs.
@en
prefLabel
Glutathione induces cellular r ...... ear platinum anticancer drugs.
@en
P2093
P1476
Glutathione induces cellular r ...... ear platinum anticancer drugs.
@en
P2093
Bart A J Jansen
Jaap Brouwer
Jan Reedijk
P304
P356
10.1016/S0162-0134(02)00381-1
P577
2002-04-01T00:00:00Z